Sagimet Biosciences (SGMT) Prepaid Assets (2022 - 2026)
Sagimet Biosciences' (SGMT) quarterly Prepaid Assets came in at $3.2 million in Q1 2026, up 111.38% year-on-year from $1.5 million in Q1 2025, and up 1496.48% quarter-over-quarter from $199000.0 in Q4 2025.
Sagimet Biosciences (SGMT) Prepaid Assets (2022 - 2026) Analysis & Trends
Sagimet Biosciences' Prepaid Assets history runs 5 years deep, the most recent figure standing at $3.2 million for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 111.38% year-over-year to $3.2 million in Q1 2026; TTM through Mar 2026 was $3.2 million, a 111.38% increase from a year earlier, with the FY2025 full-year figure at $199000.0, down 86.94% from the prior year.
- Prepaid Assets advanced to $3.2 million in Q1 2026 per SGMT's latest filing, from $199000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $3.2 million in Q1 2026 and bottomed at $34000.0 in Q4 2022.
- The 5-year median for Prepaid Assets is $378000.0 (2024), against an average of $873923.1.
- Biggest YoY gain for Prepaid Assets was 2659.41% in 2025; the steepest drop was 86.94% in 2025.
- Year by year, Prepaid Assets stood at $34000.0 in 2022, then soared by 1620.59% to $585000.0 in 2023, then surged by 160.51% to $1.5 million in 2024, then slumped by 86.94% to $199000.0 in 2025, then jumped by 1496.48% to $3.2 million in 2026.
- Per Business Quant, the three latest SGMT Prepaid Assets figures stand at $3.2 million (Q1 2026), $199000.0 (Q4 2025), and $2.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Sagimet Biosciences | 227.27 Mn | 227.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.18 Mn |
| Dec 31, 2025 | 199,000.00 |
| Sep 30, 2025 | 2.79 Mn |
| Jun 30, 2025 | 103,000.00 |
| Mar 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | 1.52 Mn |
| Sep 30, 2024 | 101,000.00 |
| Jun 30, 2024 | 378,000.00 |
| Mar 31, 2024 | 786,000.00 |
| Dec 31, 2023 | 585,000.00 |
| Sep 30, 2023 | 77,000.00 |
| Jun 30, 2023 | 107,000.00 |
| Dec 31, 2022 | 34,000.00 |